Ftg/ml), the mean concentration in all 17 patients being 1179± SE 19 4 ,ug/ml. There was a significant negative correlation between plasma fibronectin concentration and aspartate aminotransferase activity, suggesting that fibronectin is consumed during clearance of hepatocyte debris.
The reduced availability of fibronectin may be an important factor in the impaired function of Kuppfer cells in patients with fulminant hepatic failure. 
Patients and methods
The 17 patients studied had grade 3-4 encephalopathy due to fulminant hepatic failure after a paracetamol overdose (11 patients), viral hepatitis (five: four presumed non-A non-B, one hepatitis B virus), and halothane-associated hepatitis (one). Initial blood samples were taken on admission and, in eight of the patients, daily until recovery or death. On admission blood cultures in all patients were sterile; overt evidence of septicaemia (Staphylococcus aureus) developed in only one patient (case 2), on day 3 (see figure).
Blood was freshly collected into plastic tubes containing citrate (3-8% w/v) with aprotinin (1000 U/i) added to prevent proteolysis.
Samples were kept on ice and spun immediately to obtain plasma, which was stored at -20°C. Fibronectin concentrations were determined by an automated immunoturbidimetric method5 using an assay kit (Boehringer Mannheim). Plasma (5 jul) was incubated with the reaction mixture (500 ul) in a LKB reaction-rate analyser at 25°C, with the change in absorbance at 340 nm being measured after 280 s. Control values were obtained in 64 normal healthy subjects (31 men, 33 women; age range 20-81 years). Routine biochemical variables were determined daily, including liver function tests, using a Technicon Auto-Analyzer (SMAC), and the prothrombin time.
Results
On admission 13 of the 17 patients had fibronectin concentrations below the lower limit of the normal range (±2 SD, 194-472 ,g/ml); the mean concentration in all patients was significantly lower than that in the control subjects (117-9±SE 19-4 v 332-9±8-6 Ag/ml; p < 0 001, Student's t test). In the four patients with concentrations within the normal range the fulminant hepatic failure was due to viral hepatitis; the mean concentration in this group was higher than that in patients with fulminant hepatic failure due to paracetamol overdose (214-0± 15-0 v 80-5 ± 17-0 ,ug/ml; p < 0001).
No correlation was found between the initial fibronectin concentration and the depth of coma or final outcome. In four of the five patients who died and in whom serial values were obtained, however, the fibronectin concentration decreased further in the first 24 hours after admission, whereas in three patients who survived the concentration increased. Two of the patients who survived (after paracetamol overdose; cases 2 and 3) had very low initial concentrations of fibronectin, which slowly returned to normal during the course of the illness (figure). One patient (case 5), who died, was given fresh-frozen plasma on the third day, after which the concentration rose. Another patient (case 6), who had hepatitis B virus, died despite stable fibronectin concentrations. A significant negative correlation was found between fibronectin concentration and aspartate aminotransferase activity (r= -0-766, p < 0-001) and a positive correlation between fibronectin concentration and plasma total bilirubin concentration (r = 0654, p <001). In contrast, no correlation was found with serum albumin concentration (r = -0034) or the prothrombin time (r = 0213). The initial fibronectin concentration tended to be lower in patients in whom renal failure developed (urine output < 300 ml/24 h, creatinine concentration >400 ,umol/l (4 5 mg/100 ml)) compared with those with normal renal function (96-5±26-1 v 1486±266 Htg/ml), and a significant inverse correlation was found between serum creatinine and fibronectin concentrations (r =-0509, p < 0-05).
Discussion
This is the first report of reduced plasma fibronectin concentrations in patients with fulminant hepatic failure. In a recent study Matsuda et a16 found increased fibronectin concentrations in patients with uncomplicated acute hepatitis but the severity of the liver damage was considerably less than that in our patients with acute liver failure. Reduced fibronectin concentrations were found only in patients with decompensated cirrhosis. Other workers have also reported raised plasma concentrations of fibronectin in various types of liver disease including obstructive jaundice and primary biliary cirrhosis,7 and we have found normal concentrations in patients with alcoholic cirrhosis (unpublished observations).
The reduced plasma fibronectin concentration correlated most closely with the activity of aspartate aminotransferase, a cytosolic enzyme released when liver cells are damaged. 
